Role of the arylhydrocarbon receptor in lung disease

Takahito Chiba, Hiroshi Uchi, Fumiko Yasukawa, Masutaka Furue

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Ubiquitous environmental contaminants such as dioxins have long been implicated in cellular toxicity, but only recently have various biological effects been linked to immune regulation. These plentiful noxious agents exert their effects through the arylhydrocarbon receptor (AhR) recognized as a ligand-activated transcription factor. AhR activation mediates gene alteration, cell-cell adhesion interaction, cytokine expression, and mucin production, which are involved in the induction of cancer or inflammation. We have reported that human bronchial epithelial cells express AhR, and AhR activation induces mucin production through reactive oxygen species. This review discusses the role of AhR in lung disease, focusing in particular on airway epithelial cells. In addition, although it is not yet clear how the activation of AhR modifies carcinogenesis or airway inflammation, we mention a potent therapeutic target for AhR activation in the prevention/treatment of lung cancer, allergic asthma, and chronic obstructive pulmonary disease.

Original languageEnglish
Pages (from-to)129-134
Number of pages6
JournalInternational Archives of Allergy and Immunology
Volume155
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Jun 2011

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Role of the arylhydrocarbon receptor in lung disease'. Together they form a unique fingerprint.

Cite this